The FDA issuing full approval for two Covid-19 vaccines might not be the game-changer it’s chalked up to be, according to a number of leading public health experts. Increasingly, some leading academics and physicians have pushed back on the popular narrative that the FDA is needlessly delaying full approvals for the Pfizer and Moderna coronavirus shots — and spurring vaccine hesitancy by doing so.